Christina Eftychi
Impact in
- Immunology top 10%
- interferon and immune responses
- Immune Response and Inflammation
- Cancer Research top 10%
- NF-κB Signaling Pathways
Papers in
-
- Peroxisome Proliferator-Activated Receptors 1
- Ubiquitin and proteasome pathways 1
- Melanoma and MAPK Pathways 1
-
- Immune Response and Inflammation 3
- Immune cells in cancer 2
- interferon and immune responses 2
- Co-authors
- George Kollias (4 shared papers)Laurens Wachsmuth (2 shared papers)Marijana Basic (2 shared papers)Katerina Vlantis (2 shared papers)André Bleich (2 shared papers)Manolis Pasparakis (2 shared papers)Marius Dannappel (1 shared paper)Nicole Hermance (1 shared paper)
- Journals
- PLoS ONE (2 papers)Diabetes (1 paper)Journal of Clinical Investigation (1 paper)Nature (1 paper)Molecular and Cellular Biology (1 paper)
- Partner nations
- GreeceUnited KingdomGermany
In The Last Decade
Christina Eftychi
9 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 80
- Immunology 359
- Cancer Research 195
- Molecular Biology 733
- Oncology 140
- Genetics 129
Countries citing papers authored by Christina Eftychi
This map shows the geographic impact of Christina Eftychi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christina Eftychi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christina Eftychi more than expected).
Fields of papers citing papers by Christina Eftychi
This network shows the impact of papers produced by Christina Eftychi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christina Eftychi. The network helps show where Christina Eftychi may publish in the future.
Co-authors
The 25 scholars most cited alongside Christina Eftychi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 429 | |
| 2 | 2005 | 204 | |
| 3 | 2012 | 117 | |
| 4 | 2011 | 110 | |
| 5 | 2019 | 98 | |
| 6 | 2005 | 46 | |
| 7 | 2004 | 34 | |
| 8 | 2012 | 21 | |
| 9 | 2012 | 1 |
About Christina Eftychi
Christina Eftychi is a scholar working on Molecular Biology, Immunology, Cancer Research, Genetics and Surgery, having authored 9 papers that have together received 1.1k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (4 papers), Immune Response and Inflammation (3 papers), Immune cells in cancer (2 papers), interferon and immune responses (2 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (1 paper), Peroxisome Proliferator-Activated Receptors (1 paper), Ubiquitin and proteasome pathways (1 paper) and Melanoma and MAPK Pathways (1 paper). The work is most often cited by research in Immunology (359 citations), Cancer Research (195 citations), Molecular Biology (733 citations), Oncology (140 citations) and Genetics (129 citations). Christina Eftychi has collaborated with scholars based in Greece, United Kingdom and Germany. Frequent co-authors include George Kollias, Laurens Wachsmuth, Marijana Basic, Katerina Vlantis, André Bleich, Manolis Pasparakis, Marius Dannappel, Nicole Hermance, Juan Lin and Petra Kirsch. Their work appears in journals such as PLoS ONE, Diabetes, Journal of Clinical Investigation, Nature and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.